Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T17:07:23.149Z.
Calculation as of: 2026-10-06T17:07:23.149Z.
Quote observation: 2026-10-06T17:05:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12822cf5764c24a0ef00c724f2a960962c8ab94682162e48d6be38065653aaef
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$10.19B
EBITDA Yield
8.75%
TTM Avg
7.21%
3Y Avg
5.79%
5Y Avg
5.02%
Market Cap
$10.16B
EBITDA Yield
4.79%
TTM Avg
4.19%
3Y Avg
4.22%
5Y Avg
4.75%
Market Cap
$10.65B
EBITDA Yield
17.12%
TTM Avg
15.52%
3Y Avg
12.98%
5Y Avg
12.69%
Market Cap
$10.01B
EBITDA Yield
5.17%
TTM Avg
12.31%
3Y Avg
11.97%
5Y Avg
10.44%
Market Cap
$10.00B
EBITDA Yield
3.58%
TTM Avg
4.57%
3Y Avg
5.12%
5Y Avg
4.77%
Market Cap
$10.87B
EBITDA Yield
3.00%
TTM Avg
5.63%
3Y Avg
4.15%
5Y Avg
2.81%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.36B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.41B | 9.33% | 6.92% | 5.22% | 4.87% |
| Align Technology, Inc. (ALGN)vs › | $10.19B | 8.75% | 7.21% | 5.79% | 5.02% |
| The Ensign Group, Inc. (ENSG)vs › | $10.16B | 4.79% | 4.19% | 4.22% | 4.75% |
| Universal Health Services, Inc. (UHS)vs › | $10.65B | 17.12% | 15.52% | 12.98% | 12.69% |
| Repligen Corporation (RGEN)vs › | $10.08B | 1.46% | 1.65% | 1.35% | 1.70% |
| Molina Healthcare, Inc. (MOH)vs › | $10.01B | 5.17% | 12.31% | 11.97% | 10.44% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.00B | 3.58% | 4.57% | 5.12% | 4.77% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 3.00% | 5.63% | 4.15% | 2.81% |
| The Cooper Companies, Inc. (COO)vs › | $10.98B | 6.94% | 6.22% | 5.45% | 4.95% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
